|
1
|
Teitelbaum SL: Bone resorption by
osteoclasts. Science. 289:1504–1508. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tanaka Y, Nakayamada S and Okada Y:
Osteoblasts and osteoclasts in bone remodeling and inflammation.
Curr Drug Targets Inflamm Allergy. 4:325–328. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhao X, Patil S, Xu F, Lin X and Qian A:
Role of biomolecules in osteoclasts and their therapeutic potential
for osteoporosis. Biomolecules. 11:7472021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Boyle WJ, Simonet WS and Lacey DL:
Osteoclast differentiation and activation. Nature. 423:337–342.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Arai F, Miyamoto T, Ohneda O, Inada T,
Sudo T, Brasel K, Miyata T, Anderson DM and Suda T: Commitment and
differentiation of osteoclast precursor cells by the sequential
expression of c-Fms and receptor activator of nuclear factor kappaB
(RANK) receptors. J Exp Med. 190:1741–1754. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Asagiri M and Takayanagi H: The molecular
understanding of osteoclast differentiation. Bone. 40:251–264.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Feng X: RANKing intracellular signaling in
osteoclasts. IUBMB Life. 57:389–395. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Grigoriadis AE, Wang ZQ, Cecchini MG,
Hofstetter W, Felix R, Fleisch HA and Wagner EF: c-Fos: a key
regulator of osteoclast-macrophage lineage determination and bone
remodeling. Science. 266:443–448. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim K, Kim JH, Lee J, Jin HM, Lee SH,
Fisher DE, Kook H, Kim KK, Choi Y and Kim N: Nuclear factor of
activated T cells c1 induces osteoclast-associated receptor gene
expression during tumor necrosis factor-related activation-induced
cytokine-mediated osteoclastogenesis. J Biol Chem. 208:35209–35216.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim JH and Kim N: Regulation of NFATc1 in
osteoclast differentiation. J Bone Metab. 21:233–241. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rho J, Takami M and Choi Y:
Osteoimmunology: Interactions of the immune and skeletal systems.
Mol Cells. 17:1–9. 2004.PubMed/NCBI
|
|
12
|
Walsh MC, Kim N, Kadono Y, Rho J, Lee SY,
Lorenzo J and Choi Y: Osteoimmunology: Interplay between the immune
system and bone metabolism. Annu Rev Immunol. 24:33–63. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Laribi B, Kouki K, M'Hamdi M and Bettaieb
T: Coriander (Coriandrum sativum L.) and its bioactive
constituents. Fitoterapia. 103:9–26. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sahib NG, Anwar F, Gilani AH, Hamid AA,
Saari N and Alkharfy KM: Coriander (Coriandrum sativum L.): A
potential source of high-value components for functional foods and
nutraceuticals-a review. Phytother Res. 27:1439–1456. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Takami M, Cho ES, Lee SY, Kamijo R and Yim
M: Phosphodiesterase inhibitors stimulate osteoclast formation via
TRANCE/RANKL expression in osteoblasts: possible involvement of ERK
and p38 MAPK pathways. FEBS Lett. 31:832–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
O'Brien CA, Gubrij I, Lin SC, Saylors RL
and Manolagas SC: STAT3 activation in stromal/osteoblastic cells is
required for induction of the receptor activator of NF-kappaB
ligand and stimulation of osteoclastogenesis by gp130-utilizing
cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D3 or
parathyroid hormone. J Biol Chem. 274:19301–19308. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Simonet WS, Lacey DL, Dunstan CR, Kelley
M, Chang MS, Lüthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, et
al: Osteoprotegerin: A novel secreted protein involved in the
regulation of bone density. Cell. 89:309–319. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Darnay BG, Ni J, Moore PA and Aggarwal BB:
Activation of NF-kappaB by RANK requires tumor necrosis factor
receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase.
Identification of a novel TRAF6 interaction motif. J Biol Chem.
274:7724–7731. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ha H, Lee JH, Kim HN, Kim HM, Kwak HB, Lee
S, Kim HH and Lee ZH: alpha-Lipoic acid inhibits inflammatory bone
resorption by suppressing prostaglandin E2 synthesis. J Immunol.
176:111–117. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang J, Zheng H and Ma R: Natural
occurring compounds inhibit osteoclastogenesis via targeting
NFATc1-related signaling pathways. Curr Drug Targets. 21:358–364.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu C, He Y, Xu X, He L, He B and Kong L:
The study of natural compounds targeting RANKL signaling pathway
for the treatment of bone diseases. Curr Drug Targets. 21:344–357.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nicolin V, De Tommasi N, Nori SL,
Costantinides F, Berton F and Di Lenarda R: Modulatory effects of
plant polyphenols on bone remodeling: A prospective view from the
bench to bedside. Front Endocrinol (Lausanne). 10:4942019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Harsha SN and Anilakumar KR: In vitro free
radical scavenging and DNA damage protective property of Coriandrum
sativum L. leaves extract. J Food Sci Technol. 51:1533–1539. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mariezcurrena-Berasain MA,
Velázquez-Garduño G, Marín-Mendoza PM, Pliego AB, Vega Castillo LF,
Carranza BV, Khusro A, Ugbogu EA and Salem AZM: Sensitivity of
Coriandrum sativum extract on bacterial pathogens isolated from
digestive system of rabbits, and its role on in vitro cecal gas
production and fermentation. Microb Pathog. 123:18–23. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu TT, Tsai CW, Yao HT, Lii CK, Chen HW,
Wu YL, Chen PY and Liu KL: Suppressive effects of extracts from the
aerial part of Coriandrum sativum L. on LPS-induced inflammatory
responses in murine RAW 264.7 macrophages. J Sci Food Agric.
90:1846–1854. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yim MJ: The role of toll-like receptors in
osteoclastogenesis. J Bone Metab. 27:227–35. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Oganesyan ET, Nersesyan ZM and Parkhomenko
AY: Chemical composition of the above-ground part of Coriandrum
sativum. Pharm Chem J. 41:149–153. 2007. View Article : Google Scholar
|
|
28
|
Kim TH, Jung JW, Ha BG, Hong JM, Park EK,
Kim HJ and Kim SY: The effects of luteolin on osteoclast
differentiation, function in vitro and ovariectomy-induced bone
loss. J Nutr Biochem. 22:8–15. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Doss HM, Samarpita S, Ganesan R and Rasool
M: Ferulic acid, a dietary polyphenol suppresses osteoclast
differentiation and bone erosion via the inhibition of RANKL
dependent NF-kappaB signalling pathway. Life Sci. 207:284–295.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Omori A, Yoshimura Y, Deyama Y and Suzuki
K: Rosmarinic acid and arbutin suppress osteoclast differentiation
by inhibiting superoxide and NFATc1 downregulation in RAW 264.7
cells. Biomed Rep. 3:483–490. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kyung TW, Lee JE, Shin HH and Choi HS:
Rutin inhibits osteoclast formation by decreasing reactive oxygen
species and TNF-alpha by inhibiting activation of NF-kappaB. Exp
Mol Med. 40:52–68. 2008. View Article : Google Scholar : PubMed/NCBI
|
